Terasom

CEO & Co-Founder: Daniela Paňková
Websites: www.terasom.org
Email: daniela.pankova@terasom.org

About us:

Terasom is innovative, privately-held biomedical company, focused on novel exosome-based therapy and diagnostics. We use exosomes as a “cell-free delivery cargos” to target cancer, including other biological processes, associated with natural aging.

At Terasom, we believe in state-of-art interdisciplinary research and thus we have spent a significant amount of time, perfecting our projects to focus on developing exosomal treatment for patients, suffering from the lung cancer and other degenerative diseases. Our company has established the close collaboration with one of the most prestigious cancer research institutions in the world: MD Anderson Cancer Centre in USA and Oxford University in England. The big advantage of our exosomal research is that all our preclinical in vitro studies are designed and performed on advanced specific human three-dimensional spheroids co-culture models, that directly mimic related human tissues. Each of our research projects combines interdisciplinary approaches and methods, which help us to establish complex studies to apply exosomes as anti-cancer therapeutic agents.